Items where authors include "Ross, R.J.M."
Article
Lawrence, N.R. orcid.org/0000-0002-7560-0268, Keevil, B.G., Elder, C. et al. (6 more authors) (2023) OR30-01: Waking salivary 11-hydroxyandrostenedione and cortisone as a novel non-invasive test for adrenal insufficiency. Journal of the Endocrine Society, 7 (Supplement_1). bvad114.351. ISSN 2472-1972
Tschaidse, L., Reisch, N. orcid.org/0000-0002-7469-6069, Arlt, W. orcid.org/0000-0001-5106-9719 et al. (15 more authors) (2023) Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia. European Journal of Endocrinology, 188 (1). lvac006. pp. 109-117. ISSN 0804-4643
Arshad, M.F., Ogunleye, O., Ross, R.J.M. orcid.org/0000-0001-9222-9678 et al. (1 more author) (2021) Medical treatment achieves similar quality of life to surgically treated acromegaly patients in remission: the QuaLAT study. Journal of the Endocrine Society, 5 (Supplement 1). A522. ISSN 2472-1972
Neumann, U., Braune, K., Whitaker, M.J. et al. (7 more authors) (2021) A prospective study of children aged 0–8 years with CAH and adrenal insufficiency treated with hydrocortisone granules. The Journal of Clinical Endocrinology & Metabolism, 106 (3). e1433-e1440. ISSN 0021-972X
Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2020) OR25-02 A phase 3 study of a modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia. Journal of the Endocrine Society, 4 (Supplement_1).
Amarawardena, W.K.M.G., Liyanarachchi, K.D., Newell-Price, J.D.C. et al. (3 more authors) (2017) Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly. Endocrinology, Diabetes and Metabolism Case Reports, 2017 (1). 170067. ISSN 2052-0573
Karunasena, N., Han, T.S., Mallappa, A. et al. (4 more authors) (2017) Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia. Clinical Endocrinology, 86 (1). pp. 19-25. ISSN 0300-0664
Zarkesh-Esfahani, H., Pockley, A.G., Wu, Z. et al. (3 more authors) (2004) Leptin Indirectly Activates Human Neutrophils via Induction of TNF-α. Journal of Immunology, 172 (3). pp. 1809-1814. ISSN 1550-6606
Leung, K.C., Doyle, N., Ballesteros, M. et al. (6 more authors) (2003) Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proceedings of the National Academy of Sciences, 100 (3). pp. 1016-1021. ISSN 1091-6490
Zarkesh-Esfahani, H., Pockley, A.G., Metcalfe, R.A. et al. (6 more authors) (2001) High-Dose Leptin Activates Human Leukocytes Via Receptor Expression on Monocytes. Journal of Immunology, 167 (8). pp. 4593-4599. ISSN 1550-6606
Proceedings Paper
Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (13 more authors) (2024) 12670 CHAMPAIN study: initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .
Ross, R.J.M., Merke, D.P., Mallappa, A. et al. (14 more authors) (2024) 7061 Incidence of adrenal crisis in Congenital Adrenal Hyperplasia (CAH) patients during a prospective monitored long-term study of modified-release hydrocortisone (MRHC) capsules, (Efmody). In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .
Ramezani-Pour, N., Esfahani, S.H.Z., Pradhananga, S. et al. (3 more authors) (2020) SAT-396 A non-surgical animal model of hypoparathyroidism for testing PTH analogues. In: Journal of the Endocrine Society. ENDO 2020 - Annual Meeting of the Endocrine Society, 28-31 Mar 2020, San Francisco, CA, USA (cancelled). Oxford University Press (for The Endocrine Society) .
Wilkinson, I.R. orcid.org/0000-0001-6236-2419, Ramezani-Pour, N., Esfahani, S.H.Z. et al. (2 more authors) (2020) SAT-408 Bioactivity of long acting PTH fusion molecules tested in a novel non-surgical animal model of hypoparathyroidism. In: Journal of the Endocrine Society. ENDO 2020 - Annual Meeting of the Endocrine Society, 28-31 Mar 2020, San Francisco, CA, USA (cancelled). Oxford University Press (for The Endocrine Society) .